WebNov 16, 2024 · PHESGO is a combination of pertuzumab, trastuzumab, and hyaluronidase. Pertuzumab is a recombinant humanized monoclonal antibody that targets the … WebEach vial is ready-to-use for one SC injection and should not be diluted. Withdraw dose from the vial. Use 25- to 27-gauge (3/8-5/8 inch) hypodermic injection needles to inject dose. …
Resources for PHESGO® Coverage, Reimbursement and …
WebAug 6, 2024 · So this injection is a combination of Herceptin and Pertuzumab, and the nurse yesterday described it as effectively like a layer of cling film, to protect the good cells. Previously I have had Herceptin and Pertuzumab alongside chemo, given by IV drip and taking about 90mins, with flush IV in between. Phesgo is administered in 5-7 minutes and ... WebMar 16, 2024 · Phesgo 1200 mg/600 mg solution for injection Active Ingredient: trastuzumab, pertuzumab Company: Roche Products Limited See contact details ATC … florida office of chief inspector general
Phesgo Subcutaneous: Uses, Side Effects, Interactions, …
WebJun 29, 2024 · The recommended initial dose of PHESGO is 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase administered subcutaneously over approximately 8 minutes, followed every 3 weeks... WebAs an injection under your skin The combination of trastuzumab and pertuzumab as an injection under your skin is called Phesgo. Having these drugs this way is quicker than having them into your bloodstream. You usually have these every 3 weeks. Your doctor will let you know if this is suitable for you and how many treatments you will have. WebJan 27, 2024 · Dosage form: Injection ... Phesgo is initially used in combination with chemotherapy. Phesgo can be administered subcutaneously into the thigh by a health professional at home once the chemotherapy regimen is finished. Common side effects include alopecia, nausea, diarrhea, anemia, and asthenia. ... great western rail complaints